asdasda
INDEX
ABOUT JUNSHI
THERAPEUTIC AREAS
PRESS RELEASES
CAREERS
INVESTORS
CONTACT
中文简体
中文繁体
EN
Menu
INDEX
ABOUT JUNSHI
THERAPEUTIC AREAS
PRESS RELEASES
CAREERS
INVESTORS
CONTACT
中文简体
中文繁体
EN
PRESS RELEASES
Toripalimab as 1st-Line Treatment for NPC Approved in China
11-29
2021
Junshi Biosciences Announce Toripalimab Granted ODD in the US for EC
11-16
2021
TopAlliance Appoints Virginia Ellen Maher, MD, as Vice President of Medical Sciences
11-01
2021
US FDA Accepted BLA Filing for Toripalimab for Treatment of NPC
10-31
2021
More
Back
List
//